Ramagiri Sruthi, Taliyan Rajeev
Laboratory of Neuropharmacology, Department of Pharmacy, BITS Pilani, Pilani campus, Rajasthan 333031, India.
Laboratory of Neuropharmacology, Department of Pharmacy, BITS Pilani, Pilani campus, Rajasthan 333031, India.
Eur J Pharmacol. 2017 May 15;803:84-93. doi: 10.1016/j.ejphar.2017.03.028. Epub 2017 Mar 21.
Remote limb ischemic post conditioning (RIPOC) has been reported to attenuate cerebral ischemic reperfusion (I/R) injury, while the molecular mechanisms remain elusive. Various studies have highlighted the involvement of glycogen synthase kinase (GSK-3β) in cerebral I/R injury and cognitive disorders. Hence, the present study was designed to explore the role of GSK-3β and its downstream regulators in RIPOC mediated neuroprotection against cerebral I/R injury and associated cognitive impairment. Male Wistar rats are randomly assigned into four groups: Sham, bilateral common carotid arteries occlusion (BCCAO), RIPOC and BCCAO+RIPOC. BCCAO was achieved by transient occlusion of bilateral common carotid arteries for 20min, followed by reperfusion. Non-invasive RIPOC was induced by 3 cycles each of 10min occlusion and reperfusion of both femoral arteries by using tourniquets, during early reperfusion phase. A battery of behavioral and cognitive tests were performed. Biochemical estimation of oxidative markers, anti-oxidants and pro-inflammatory markers were estimated. Levels of GSK-3β, CREB and BDNF were estimated to confirm the molecular mechanism. Hippocampal structural abnormalities were confirmed by H and E staining. The neurobehavioral analysis revealed that neurological and cognitive deficits caused by BCCAO, were reduced by RIPOC intervention. Meanwhile, the results of biochemical tests suggested that RIPOC attenuates the BCCAO induced oxidative damage, neuroinflammation and hippocampal structural abnormalities. Further, RIPOC prevented the elevation of BCCAO induced GSK-3β. RIPOC exerts neuroprotective effect against I/R injury, putatively by attenuating GSK-3β expression and upregulating the levels of CREB and BDNF.
据报道,远程肢体缺血后处理(RIPOC)可减轻脑缺血再灌注(I/R)损伤,但其分子机制仍不清楚。各种研究强调了糖原合酶激酶(GSK-3β)参与脑I/R损伤和认知障碍。因此,本研究旨在探讨GSK-3β及其下游调节因子在RIPOC介导的针对脑I/R损伤及相关认知障碍的神经保护中的作用。将雄性Wistar大鼠随机分为四组:假手术组、双侧颈总动脉闭塞(BCCAO)组、RIPOC组和BCCAO+RIPOC组。通过短暂闭塞双侧颈总动脉20分钟,然后再灌注来实现BCCAO。在早期再灌注阶段,使用止血带对双侧股动脉进行每次10分钟的闭塞和再灌注,共3个周期,诱导非侵入性RIPOC。进行了一系列行为和认知测试。对氧化标志物、抗氧化剂和促炎标志物进行了生化评估。评估了GSK-3β、CREB和BDNF的水平以确认分子机制。通过苏木精和伊红(H&E)染色确认海马结构异常。神经行为分析表明,RIPOC干预减少了BCCAO引起的神经和认知缺陷。同时,生化测试结果表明,RIPOC减轻了BCCAO诱导的氧化损伤、神经炎症和海马结构异常。此外,RIPOC阻止了BCCAO诱导的GSK-3β升高。RIPOC可能通过减弱GSK-3β表达并上调CREB和BDNF水平,对I/R损伤发挥神经保护作用。